Management ChangeJun 5, 2026, 04:13 PM
OptimizeRx CCO Theresa Greco Departs; Receives $589K Severance
AI Summary
OptimizeRx announced the departure of its Chief Commercial Officer, Theresa Greco, effective June 15, 2026. In connection with her separation, Ms. Greco will receive a severance package including 12 months of her $380,000 base salary, a $209,000 annual cash bonus, and COBRA premium reimbursements. She will also provide advisory services to the company for 12 months, during which her equity will continue to vest.
Key Highlights
- Chief Commercial Officer Theresa Greco departs OptimizeRx effective June 15, 2026.
- Ms. Greco will receive 12 months of her $380,000 base salary continuation.
- She will also get a one-time lump sum payment of her $209,000 annual cash bonus target.
- OptimizeRx will reimburse COBRA premiums for 12 months for health, dental, and vision benefits.
- Ms. Greco will provide advisory services to the company for 12 months, through June 15, 2027.
- Equity previously granted to Ms. Greco will continue to vest during the advisory term.
- She is subject to 12-month non-compete and non-solicitation obligations.
Price Impact
More from OPRX